Imaging may provide a new tool to track progression of calcific aortic-valve disease

November 7, 2017 by Taylor Mcneil
A 3D projection from a calcific nodule grown in a cell culture model of valve disease. “We saw that calcification occurs with varying rates and degrees, sometimes disappearing in spots even as the overall calcification increases,” said Lauren Baugh. Credit: Tufts University

Almost a half million Americans aged 65 to 74 suffer from a degenerative cardiovascular disease caused by calcium being deposited in heart tissue, and many will need valve replacement surgery to prevent heart failure. Currently there is no good way to measure the progression of the disease—called calcific aortic-valve disease, or CAVD—and the exact mechanism by which the disease progresses isn't well understood.

Now researchers at Tufts have developed a way to image the early stages of the disease, allowing them to track how the calcium is deposited and grows in the aortic valve tissue in much greater detail than before. The end result, they said, could be better understanding of CAVD and other diseases, such as breast cancer, and the development of more effective treatments. The research was a collaborative effort between the labs of professors Lauren D. Black III and Irene Georgakoudi, both in the Department of Biomedical Engineering, and was published on November 6 in Nature Biomedical Engineering.

Called two-photon excited fluorescence imaging, or TPEF, the imaging technology uses near-infrared light to create the , and, unlike some methods, does not destroy the tissue in the process.

"Our results indicate that TPEF imaging may provide a new tool to non-destructively quantify mineralization [of the heart valve] with high sensitivity and spatial resolution during CAVD progression," the researchers wrote.

In CAVD, which primarily affects older people and some younger patients who have a genetic defect, "the soft valve tissue stiffens to the point of hindering normal opening and closing of the valve," said Lauren Baugh, a doctoral student in Black's lab and first author of the paper. In some cases, Baugh added, "the tissue develops bone-like nodules, further impeding blood flow."

As the researchers started using TPEF imaging, they discovered that by focusing on one particular part of the signal generated, they were able to isolate the calcification process, and could track development of the bone-like nodules. "We saw that calcification occurs with varying rates and degrees, sometimes disappearing in spots even as the overall calcification increases," said Baugh.

For their testing, the researchers used samples from human CAVD patients, animal bone fragments, and calcified nodules that were grown in the lab.

TPEF provides much higher resolution than current imaging technologies used in diagnosing CAVD, such as traditional computer tomography (CT) scans, ultrasound, and magnetic resonance imaging. It "bears great promise as a tool that may be used to detect and dynamically monitor the development of mineralized deposits from a very early stage," the researchers wrote.

"We believe that this technique currently has a wide range of applications in studying the calcifications in diseased states as well as in the visualization of healthy mineralization such as in bone and tooth tissue engineering," said Georgakoudi. "As optical probe technology improves, this system could be used in people to aid with CAVD diagnosis, in determining the stability of atherosclerotic plaques, or in determining prognosis, by providing high resolution images, within the context of the natural environment."

Explore further: Scientists discover why some heart tissue turns into bone

More information: Lauren M. Baugh et al. Non-destructive two-photon excited fluorescence imaging identifies early nodules in calcific aortic-valve disease, Nature Biomedical Engineering (2017). DOI: 10.1038/s41551-017-0152-3

Related Stories

Scientists discover why some heart tissue turns into bone

March 12, 2015
Researchers from the Gladstone Institutes have used human cells to discover how blood flow in the heart protects against the hardening of valves in cardiovascular disease. What's more, they've identified a potential way to ...

Longer telomeres protect against diseases of aging: A tale of mice and men

March 27, 2017
Scientists at the Gladstone Institutes discovered a key mechanism that protects mice from developing a human disease of aging, and begins to explain the wide spectrum of disease severity often seen in humans. Both aspects ...

New study offers high-resolution images of heart valves

September 8, 2017
On Aug. 30, a team led by associate professor of biomedical engineering Morten Jensen published an article in the scientific journal PLOS ONE titled "High resolution imaging of the mitral valve in the natural state with ...

Study shows low mortality and stroke risks for minimally invasive aortic valve replacements

October 5, 2017
An analysis of more than 1,000 minimally invasive aortic valve replacements and more than 400 additional associated procedures over a five-and-a-half year period performed by Dr. Joseph Lamelas, professor and associate chief ...

FDA expands approval for 'valve in valve' aortic replacement

March 31, 2015
(HealthDay)—The U.S. Food and Drug Administration said Tuesday that use of the CoreValve "valve-in-valve" aortic replacement has been expanded to include people at extreme risk for serious complications of traditional ...

Drug developed for arthritis could be first to stop heart valve calcification

June 12, 2017
The first drug to treat calcification of heart valves may be one originally designed for rheumatoid arthritis.

Recommended for you

Some cancer therapies may provide a new way to treat high blood pressure

November 20, 2017
Drugs designed to halt cancer growth may offer a new way to control high blood pressure (hypertension), say Georgetown University Medical Center investigators. The finding could offer a real advance in hypertension treatment ...

Could this protein protect people against coronary artery disease?

November 17, 2017
The buildup of plaque in the heart's arteries is an unfortunate part of aging. But by studying the genetic makeup of people who maintain clear arteries into old age, researchers led by UNC's Jonathan Schisler, PhD, have identified ...

Raising 'good' cholesterol fails to protect against heart disease

November 16, 2017
Raising so-called 'good' cholesterol by blocking a key protein involved in its metabolism does not protect against heart disease or stroke, according to a large genetic study of 150,000 Chinese adults published in the journal ...

Popular e-cigarette liquid flavorings may change, damage heart muscle cells

November 16, 2017
Chemicals used to make some popular e-cigarette liquid flavorings—including cinnamon, clove, citrus and floral—may cause changes or damage to heart muscle cells, new research indicates.

New model estimates odds of events that trigger sudden cardiac death

November 16, 2017
A new computational model of heart tissue allows researchers to estimate the probability of rare heartbeat irregularities that can cause sudden cardiac death. The model, developed by Mark Walker and colleagues from Johns ...

Possible use for botulinum toxin to treat atrial fibrillation

November 16, 2017
From temporarily softening wrinkles to easing migraines, botulinum toxin has become a versatile medical remedy because of its ability to block nerve signals that can become bothersome or risky.


Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.